EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Risk Factors for Potential Drug-Drug Interactions in Patients on Chronic Peritoneal Dialysis

Milorad Stojadinovic, Mirjana Lausevic, Iman Assi Milosevic, Radica Zivkovic Zaric, Tamara Kosta Jemcov, Ljiljana Komadina, Dejan Slavko Petrovic, Petar Djuric, Ana Bulatovic, Stefan Jakovljevic, Slobodan Jankovic

Pharmacology · 2024

DOI: 10.1159/000537968 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Pharmacology, 2024. Verfasst von Milorad Stojadinovic und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, University Clinical Center of Serbia, Belgrade, Serbia. Hauptthemen laut MEDLINE: Peritoneal Dialysis, Drug Interactions. Die Arbeit nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The prevalence of potential drug-drug interactions (pDDIs) is becoming a major safety concern, as it has been previously linked to a significant number of adverse drug events and could have serious consequences for patients, including death. This is especially relevant for patients with chronic renal failure, as they are particularly vulnerable to drug-drug interactions. The aim of this study was to evaluate the prevalence and associated factors of pDDIs in patients receiving chronic peritoneal dialysis.

Methods

An observational, cross-sectional study was conducted on consecutive peritoneal dialysis patients attending four tertiary care hospitals for regular monthly examination. The primary outcome was the number of pDDIs identified using Lexicomp. Potential predictors were determined using multiple linear regression.

Results

Total number of patients included in the study was 140. The results showed that pDDIs were highly prevalent, especially in patients who use antiarrhythmics (p = 0.001), have diabetes mellitus (p = 0.001), recently started peritoneal dialysis (p = 0.003), or have higher number of prescribed drugs (p < 0.001). Number of prescribed drugs (p < 0.001) remained a significant predictor of high-risk pDDIs in addition to the female gender (p = 0.043).

Conclusion

Clinicians should be particularly cautious when prescribing multiple medications to high-risk patients, such as peritoneal dialysis patients, to mitigate the risk of drug-drug interactions and associated adverse health outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peritoneal DialysisDrug InteractionsHumansMaleFemaleMiddle AgedCross-Sectional StudiesRisk FactorsAgedAdultKidney Failure, ChronicPrevalencePolypharmacy

Stichwörter der Autor:innen

ComorbiditiesDrug-drug interactionsPeritoneal dialysisPolypharmacy

Autor:innen und Institutionen

  • Department of Nephrology, University Clinical Center of Serbia, Belgrade, Serbia.
  • Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.
  • Medical Faculty, University of Belgrade, Belgrade, Serbia.
  • Department of Nephrology, Clinical Hospital Centre Zemun, Belgrade, Serbia.
  • Department of Nephrology, University Clinical Center of Kragujevac, Kragujevac, Serbia.
  • Department of Nephrology, Clinical Hospital Centre Zvezdara, Belgrade, Serbia.

Zitieren

APA

Stojadinovic, M., Lausevic, M., Milosevic, I. A., Zaric, R. Z., Jemcov, T. K., Komadina, L., Petrovic, D. S., Djuric, P., Bulatovic, A., Jakovljevic, S., & Jankovic, S. (2024). Risk Factors for Potential Drug-Drug Interactions in Patients on Chronic Peritoneal Dialysis. Pharmacology. https://doi.org/10.1159/000537968

Vancouver

Stojadinovic M, Lausevic M, Milosevic IA, Zaric RZ, Jemcov TK, Komadina L, et al. Risk Factors for Potential Drug-Drug Interactions in Patients on Chronic Peritoneal Dialysis. Pharmacology. 2024. doi:10.1159/000537968

BibTeX
@article{Stojadinovic2024,
  author = {Stojadinovic, Milorad and Lausevic, Mirjana and Milosevic, Iman Assi and Zaric, Radica Zivkovic and Jemcov, Tamara Kosta and Komadina, Ljiljana and Petrovic, Dejan Slavko and Djuric, Petar and Bulatovic, Ana and Jakovljevic, Stefan and Jankovic, Slobodan},
  title = {Risk Factors for Potential Drug-Drug Interactions in Patients on Chronic Peritoneal Dialysis},
  journal = {Pharmacology},
  year = {2024},
  doi = {10.1159/000537968}
}
Kostenlos starten →